Answer:

The European Pharmacopoeia Commission decides on a work programme formulated on the basis proposals submitted by, , national pharmacopoeia authorities, groups of experts, manufacturers and the EDQM.

Manufacturers willing to assist in the drafting of a monograph, by providing data and samples for approved products and by verifying the draft monograph, are encouraged to send monograph proposals.